# K073162: Safe-Cross (R) Radio Frequency Total Occlusion Crossing System, Safe-Cross (R) Radio Frequency Total Occlusion Crossing

- Pathway: 510(k) (Special)
- Applicant: Kensey Nash Corporation
- Decided: Feb 8, 2008 after 91 days
- Product code: DQX (Wire, Guide, Catheter)
- Device class: 2
- Regulation: 21 CFR 870.1330
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K890505 (1989). 13 ancestors in all.
No later device cites it as a predicate yet.
0 of 14 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K050915: Safe-Cross Radio Frequency Total Occlusion Crossing System [Coronary], Intra Luminal Therapeutics, Inc. (2005) Summary page 1.
- K050916: Safe-Cross Radio Frequency Total Occlusion Crossing System [Peripheral], Intra Luminal Therapeutics, Inc. (2005) Summary page 1.

## Indications for use
The Safe-Cross® Radio Frequency Total Occlusion Crossing System is indicated for use in facilitating the placement of devices used in percutaneous interventions in native coronary and peripheral arteries with total occlusions. The device is not to be used in the carotid arteries.

Source page: https://510kreport.com/device/K073162
Methodology: https://510kreport.com/methodology